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Subit Barua1, Salomon Kuizon1, Kathryn K Chadman2, Michael J Flory3, W Ted Brown4 and Mohammed A Junaid1,5*Abstract
Background: Epigenetic modifications, such as cytosine methylation in CpG-rich regions, regulate multiple functions in
mammalian development. Maternal nutrients affecting one-carbon metabolism during gestation can exert long-term
effects on the health of the progeny. Using C57BL/6 J mice, we investigated whether the amount of ingested maternal
folic acid (FA) during gestation impacted DNA methylation in the offspring’s cerebral hemispheres. Reduced
representation bisulfite sequencing at single-base resolution was performed to analyze genome-wide DNA
methylation profiles.
Results: We identified widespread differences in the methylation patterns of CpG and non-CpG sites of key
developmental genes, including imprinted and candidate autism susceptibility genes (P <0.05). Such differential
methylation of the CpG and non-CpG sites may use different mechanisms to alter gene expressions. Quantitative real
time reverse transcription-polymerase chain reaction confirmed altered expression of several genes.
Conclusions: These finding demonstrate that high maternal FA during gestation induces substantial alteration in
methylation pattern and gene expression of several genes in the cerebral hemispheres of the offspring, and such
changes may influence the overall development. Our findings provide a foundation for future studies to explore the
influence of gestational FA on genetic/epigenetic susceptibility to altered development and disease in offspring.Background
The folate cycle, in conjunction with one-carbon metab-
olism, facilitates nucleic acid synthesis and is responsible
for the transfer of 1-carbon methyl groups to DNA and
proteins. Methyl groups added onto cytosine residues in
promoter region CpGs in genomic DNA are central to
the regulation of gene expression [1,2]. The role of folic
acid (FA) in preventing neurodevelopmental disorders
and birth defects has long been recognized, and as such,
its use during pregnancy is strongly emphasized [3-5].
Dietary FA supplementation is credited with a greater
than 70% reduction in the incidence of neural tube defects
(NTDs) in the US [6]. There has been speculation that FA* Correspondence: mohammed.junaid@opwdd.ny.gov
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reproduction in any medium, provided the orsupplementation may be associated with certain aberrant
conditions in children [7-9], and a clear understanding of
this purported association is essential in view of the pres-
ence of significant amounts of synthetic FA in our diets.
Earlier, we reported that exposure of lymphoblastoid cells
to FA supplementation causes widespread changes in gene
expression [10]. We suggested that the occurrence of such
epigenetic changes during gestational development may
impact the methylation status of DNA in the offspring’s
brain and cause altered gene expression. Because gesta-
tional development involves a highly orchestrated regula-
tion of gene expression, such gene dysregulation may
affect the development of the brain and may culminate in
neuropsychiatric conditions. This could be a contributing
factor to the increasing prevalence in recent years.
To test the hypothesis that excess FA supplementation
could alter the methylation in the brains of offspring, 1
week prior to mating, a group of C57BL/6 J female mice
were fed a custom AIN-93G amino acid-based diet (Re-
search Diet, Inc., New Brunswick, NJ, USA), with FA attd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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(high maternal folic acid, or HMFA). FA at the 4 mg/kg
level is above the range currently included in mice chow,
whereas the 0.4 mg/kg level of FA has been found to be
necessary for a normal healthy litter size [11]. FA at the 4
mg/kg level in mice roughly corresponds to the 4 mg/day
dose in humans, which is the level of FA supplementation
(4 mg/day) prescribed to women with a history of NTD
pregnancy. We used an amino acid-based diet to pre-
cisely control the amount of FA in the diet. To under-
stand the dynamics of DNA methylation, genomic
DNA from the cerebral hemispheres of the offspring
was isolated at postnatal day 1 segregated by gender,
and high-resolution, single-base DNA methylation pro-
filing was performed by using next-generation Illumina
(Illumina Inc., San Diego, CA, USA) sequencing (details
in the Methods section).
Results
Global DNA methylation patterns of the offspring’s
cerebral hemispheres from high maternal folic acid
The final DNA methylation map presented in this study
represents the summary of three biological replicates
[12,13], with each mouse collected from an independent
litter. On average, the sequence depths of unique CpG
sites in our study were 4,647,138 (11 times) for male and
4,410,480 (14 times) for female DNA samples (Additional
file 1: Table S1), and about 90% of the CpG islands were
covered. To investigate the differentially methylated re-
gions (DMRs), sequence alignment and Fisher’s exact test
or t test were performed for each CpG site that had at
least five reads covered. Results of global methylation
comparison revealed that approximately 16% of the CpG
sites were differentially methylated in both male and fe-
male pups from HMFA (n = 43,010 for male, n = 57,602
for female). The majority of the CpG island-associated
DMRs were either intergenic or in introns, whereas 18%
to 19% were in exons, and approximately 7% were in pro-
moter regions (Figure 1a, b). Several genes involved in
neural functioning, brain development, and synaptic plas-
ticity were differentially methylated (P <0.05) in the CpG
sites of the offspring from HMFA (Tables 1, 2, 3 and 4,
Additional file 2: Table S2, Additional file 3: Table S3,
Additional file 4: Table S5, and Additional file 5: Table S6).
The results of high-resolution global DNA methylation
profiling indicated that maternal FA induces significant
changes in the overall methylation patterns in the brains of
the offspring. The correlations of the distribution of methy-
lation ratios in male and female pups for the corresponding
sites in LMFA and HMFA are shown in Additional file 6:
Figures S1-S6, and the distributions of the overlapped sites
between LMFA and HMFA male with that of LMFA and
HMFA female differential methylation sites (P <0.05) are
shown as a hexbin plot in Additional file 7: Figures S7-S9.Maternal folic acid alters DNA methylation status in the
promoters at CpG Islands
In this study, we found that HMFA throughout gestation
resulted in hypermethylation (P <0.01) at CpG sites of
the promoter region of several genes, including Ada,
Bag5, and Trap1 in male offspring (Table 1), leading to
downregulation of the expression of Ada and Bag5 and
no such alterations in expression level of Trap1 (Figure 2a).
In female pups, HMFA also resulted in hypermethylation
at CpG sites in the promoter region of the genes Dio3,
Polg2, Rnf111, and Ube2s, including several other genes
(Table 1). Quantitative real time reverse transcription-
polymerase chain reaction (qRT-PCR) analysis revealed
that the expression of Dio3 was significantly downregu-
lated and that, in contrast, the expression of Polg2, Rnf111,
and Ube2s remained unchanged in female pups from
HMFA compared with that of LMFA (Figure 2b). To fur-
ther reveal the impact of maternal FA, we assessed whether
HMFA resulting in hypomethylation in the promoter re-
gions of CpG islands altered the expression levels of those
genes as well. We tested the expression of several genes in
male (Pcnxl3, Hmgb21l, and Ror2) and female (Mrps12,
Ceacam2, andMtap4) pups (Table 1, Figure 2c, d). In male
pups from HMFA, the expressions of Ror2 and Mrps12
were significantly downregulated, and in female pups, the
expression of Mtap4 was significantly upregulated in com-
parison with LMFA. Interestingly, although the methyla-
tion level ofMrps12 did not show any significant change in
male pups from HMFA, the expression was significantly
downregulated. In contrast, the expression of Mrps12 in
female pups from HMFA showed no difference in expres-
sion level, although significant methylation changes were
observed. However, the expression analysis of several
other genes—Pcnxl3, Hmgb21l, Mtap4, and Ceacam2—
has shown no significant changes in both the genders
from HMFA. The results of our findings suggest that
maternal FA modulates the methylation pattern of the
offspring genome, and considering the role of maternal
nutrition in early neural development, such changes in
methylation patterns in promoter CpG sites due to HMFA
may have long-term influences on neuronal organization
and ultimately on behavioral phenotypes.
Maternal folic acid alters DNA methylation status in the
promoters at non-CpG sites
To extend our findings, we then analyzed whether gesta-
tional FA modulates the methylation pattern of non-CpG
sites. In this study, we obtained 89% coverage in non-CpG
sites (both CHH and CHG context, where H =A, C, or T).
The overall distribution of methylation level in the non-
CpG sites is shown in Additional file 8: Figures S10
and 11. We identified approximately 1,000 differentially
methylated (both hyper- and hypo-methylation) sites
(P <0.05) in both CHH and CHG contexts in the offspring
Figure 1 Distribution of differentially methylated sites in CpG island sequences. (a) Male low maternal folic acid (LMFA) versus high maternal
folic acid (HMFA). (b) Female LMFA versus HMFA.
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S2, Additional file 3: Table S3, Additional file 9: Table S4,
Additional file 4: Table S5, and Additional file 5: Table S6).
For example, zinc finger proteins Zfp608 and ephrin recep-
tor Epha6 in male offspring and Zfp719, Zfp804b, Zfp128
and calcium channel Cacna1g in female offspring are a few
of the many genes that were hypermethylated (P <0.05) in
the non-CpG promoter sites (Additional file 9: Table S4).
Furthermore, we tested expression levels of several genes
(Ghr, Slc5a1, and 4732418C07Rik) in male pups and (Tshz3
and Trim7) in female pups with Quantitative real time
reverse transcription-polymerase chain reaction (qRT-
PCR). The results showed that the expression of EF-hand
calcium-binding domain 14 (4732418c07Rik) remain un-
changed; in contrast, the expression of sodium-dependent
glucose transporter (Slc5a1), which exhibited hypermethy-
lation in CHG sites, and growth hormone receptor (Ghr)
[14], which exhibited hypermethylation at both CHG and
CHH sites in the promoter region, were downregulated in
male offspring from HMFA (Figure 2a, Additional file 9:
Table S4). A representative figure depicting the methyla-
tion status of a non-CpG (CHG) hypermethylation at
Slc5a1 promoter of male offspring from the data uploaded
in the UCSC Genome Browser is shown in Additional
file 10: Figure S12.
Maternal folic acid alters DNA methylation pattern in the
gene body
An interesting aspect of our data is the pattern of methy-
lation in both CpG and non-CpG sites in gene bodies.The majority of the non-CpG associated DMRs were
either intergenic or in introns, whereas 10% to 11%
were in exons, and approximately 16% to 21% were in
promoter regions in both male and female pups from
HMFA (Figure 3a, b). The overall distribution of methyla-
tion level in exons is shown in Additional file 11: Figure
S13 and S14. Several candidate autism susceptibility genes
[15] were hypermethylated (P <0.05) in the HMFA, in-
cluding Shank3, Cacana1g, Gtf2i, Rapgef4, and Nbea in
male offspring and Ext1, Ube3a, Erbb4, Grip1, Grm8,
Reeln, Shank3, and Rbfox1 in female offspring (Additional
file 2: Table S2 and Additional file 3: Table S3). In con-
trast, several candidate autism susceptibility genes were
also hypomethylated; for example, Disc1, which is known
to play a pivotal role in cortical development, and Scn8a,
which modulates membrane depolarization, were hypo-
methylated in the gene body in both male and female off-
spring (P <0.05) in the HMFA group (Additional file 4:
Table S5 and Additional file 5: Table S6). It is interesting
to note that autism susceptibility candidate 2 (Auts2) gene
exhibited both hyper- and hypo-methylation in the gene
bodies of male and female pups from HMFA. Further ana-
lysis of methylation profile also revealed hypermethylation
in imprinted genes in male (Slc22a3 and Ano1) and in fe-
male (Gab1, Calcr, Dio3, and Slc38a4) offspring (P <0.05)
(Additional file 2: Table S2 and Additional file 3: Table
S3). On the other hand, imprinted genes Peg12 and
Slc22a18 in female offspring and cadherin-associated pro-
tein Ctnna3 in both male and female offspring from the
HMFA group were hypomethylated (Additional file 4:
Table 1 List of hypermethylated CpG sites in the promoter of genes from high maternal folic acid diet








Chr1 174430052 174430053 Tagln2 12 5 −0.80 0.00
Chr2 124976701 124976702 Slc12a1 9 10 −0.79 0.00
Chr2 163576501 163576502 Ada 7 5 −0.80 0.01
Chr5 110658438 110658439 Ankle2 10 6 −0.80 0.01
Chr7a 25654980 25654981 Dmrtc2 5 5 −1.00 0.01
Chr12a 112951515 112951516 Bag5 20 5 −0.80 0.00
Chr13 21533599 21533600 Pgbd1 11 5 −0.91 0.00
Chr14 12384528 12384529 Ptprg 15 6 −0.87 0.00
Chr16 4078495 4078496 Trap1 17 20 −0.85 0.00
Chr18a 25327450 25327451 AW554918 11 10 −0.80 0.00
Chr18 55150289 55150290 Zfp608 8 5 −0.80 0.01
ChrX 70963189 70963190 Bcap31 15 7 −0.80 0.00
Female-CpG
Chr1 158239364 158239365 Nphs2 5 5 −0.80 0.05
Chr2 30141110 30141111 Nup188 10 9 −0.78 0.00
Chr2 93663150 93663151 Ext2 7 9 −0.78 0.00
Chr4 115456244 115456245 Atpaf1 10 5 −0.80 0.01
Chr7 4765788 4765789 Ube2s 12 14 −0.79 0.00
Chr7 116076508 116076509 Eif3f 8 10 −0.80 0.00
Chr9 43921237 43921238 Rnf26 10 6 −0.80 0.01
Chr9 43921243 43921244 Rnf26 10 6 −0.80 0.01
Chr9 70352700 70352701 Rnf111 7 6 −1.00 0.00
Chr11a 106640875 106640876 Polg2 8 8 −0.75 0.01
Chr12a 111517321 111517322 Dio3 8 8 −0.75 0.01
Chr13 3147545 3147546 Speer6-ps1 6 5 −0.80 0.02
Chr13 38751553 38751554 Eef1e1 10 6 −0.80 0.01
Chr16 18624289 18624290 Gp1bb 8 5 −0.75 0.02
Chr17 24806277 24806278 Zfp598 7 6 −0.86 0.00
Chr18a 51277441 51277442 Prr16 7 5 −0.80 0.01
Chr18 60932782 60932783 Rps14 5 9 −0.78 0.02
ChrX 7721523 7721524 2900002K06Rik 6 13 −0.76 0.00
ChrXa 155852426 155852427 Mtap7d2 14 17 −0.82 0.00
aMethylation exclusively in the CpG island of promoter region. HMFA, high maternal folic acid; LMFA, low maternal folic acid.
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in the expression levels, we tested the mRNA expression of
several genes by qRT-PCR. Genes in male pups (Auts2,
Mthfd1l, Mtnr1b, Nfix, Otoa, Runx1, Shank3, Slc22a3, and
Wif1) and in female pups (Auts2, Gab1, Lats2, Runx1,
Wif1, Mthfd1, Shank3, and Slc25a13) were analyzed. The
results revealed that the expressions of Auts2, Nfix, Otoa,
Runx1, Shank3, and Slc22a3 were significantly downregu-
lated; in contrast, the expression of Mthfd1l, Mtnr1b, and
Wif1 did not exhibit significant changes as a result ofHMFA in comparison with LMFA in male pups (Figure 2a).
In female pups from the HMFA group, the expression of
Auts2, Gab1, Lats2, Runx1, Wif1, and Mthfd1 did not ex-
hibit significant changes; in contrast, the expressions of
Shank3 and Slc25a13 were significantly downregulated
(Figure 2b). We further analyzed the expression of several
genes which exhibited hypomethyaltion in the gene body
of several genes (Cd47, Disc1, Dnm3, Evl, Sn8a, and
Homer2) in both male and female pups from HMFA in
comparison with LMFA (Figure 2c, d). The result of gene
Table 2 List of hypomethylated CpG sites in the promoter of genes from high maternal folic acid diet








Chr2 104335383 104335384 Hipk3 6 10 −0.80 0.01
Chr2 118590048 118590049 A430105I19Rik 6 7 −0.83 0.00
Chr2 164156736 164156737 Svs5 5 6 −0.83 0.02
Chr2 171789984 171789985 1700028P15Rik 17 5 −0.80 0.00
Chr4 135283630 135283631 Il22ra1 5 5 −0.80 0.05
Chr5 122070856 122070857 Acad12 6 11 −0.73 0.01
Chr7 3219409 3219410 Mir291b 8 11 −0.75 0.00
Chr7 7253725 7253726 Clcn4-2 6 9 −0.72 0.01
Chr7a 15208940 15208941 Gm18756 10 12 −0.83 0.00
Chr7 91836603 91836604 2610206C17Rik 6 5 −0.83 0.02
Chr8 34495178 34495179 Purg 5 5 −0.80 0.05
Chr8 73034757 73034758 Uba52 6 6 −0.83 0.02
Chr8 77516944 77516945 Hmgxb4 6 15 −0.77 0.00
Chr9 66892554 66892555 Tpm1 15 6 −0.73 0.00
Chr10 53239171 53239172 Gm20597 8 7 −0.75 0.01
Chr12 3235150 3235151 1700012B15Rik 16 18 −0.88 0.00
Chr13 53382125 53382126 Ror2 6 5 −0.80 0.02
Chr13 53382128 53382129 Ror2 6 5 −1.00 0.00
Chr13 97839933 97839934 Fam169a 5 8 −0.75 0.02
Chr13 100671338 100671339 Cartpt 5 5 −0.80 0.05
Chr14 67628989 67628990 Bnip3l 7 8 −0.75 0.01
Chr19 5690281 5690282 Pcnxl3 20 13 −0.80 0.00
Female-CpG
Chr2 127618583 127618584 1500011K16Rik 11 20 −0.85 0.00
Chr5a 100468191 100468192 Enoph1 11 5 −0.71 0.01
Chr6a 52196197 52196198 Hoxa11 5 5 −0.80 0.05
Chr6 100476908 100476909 1700049E22Rik 10 5 −0.80 0.00
Chr7 26326796 26326797 Ceacam2 6 15 −0.77 0.00
Chr7 29528469 29528470 Mrps12 16 5 −0.80 0.00
Chr7 86988105 86988106 Anpep 12 5 −0.83 0.00
Chr8 87469964 87469965 Rtbdn 7 6 −0.86 0.00
Chr8 116657191 116657192 Nudt7 14 5 −0.71 0.01
Chr9 109833746 109833747 Mtap4 8 14 −0.71 0.00
Chr10 76992742 76992743 Itgb2 8 7 −0.71 0.01
Chr10 80846466 80846467 Dohh 8 13 −0.69 0.00
Chr11 88727116 88727117 Akap1 6 5 −0.80 0.02
Chr11 115184397 115184398 Ush1g 12 5 −0.75 0.01
Chr11 118204319 118204320 BC100451 20 7 −0.81 0.00
Chr11 119909421 119909422 Aatk 7 5 −0.71 0.03
Chr11 120051942 120051943 2810410L24Rik 10 5 −0.70 0.02
Chr12 52447904 52447905 G2e3 8 5 −0.75 0.02
Chr14a 63380523 63380524 Ints6 5 6 −0.80 0.02
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Table 2 List of hypomethylated CpG sites in the promoter of genes from high maternal folic acid diet (Continued)
Chr15 81561248 81561249 Rangap1 13 5 −0.72 0.01
Chr17 52020946 52020947 Gm20098 9 7 −0.71 0.00
Chr18 38762241 38762242 Spry4 6 5 −0.83 0.02
Chr18 60933042 60933043 Rps14 9 8 −0.76 0.00
Chr19 7070128 7070129 Trpt1 8 6 −0.71 0.03
aMethylation exclusively in the CpG island of promoter region. HMFA, high maternal folic acid; LMFA, low maternal folic acid.
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tion in the expression of Evl and Homer2 whereas no such
significant differences in expression of Cd47, Disc1, Dnm3,
and Sn8a were observed. In contrast, in female pups, the
expression of Sn8a was downregulated and the expres-
sions of Cd47, Disc1, and Evl were upregulated whereas
the expression of Dnm3 did not exhibit any change in
expression.
Maternal folic acid modulates sex-specific alterations
in global DNA methylation in the offspring’s
cerebral hemispheres
We further investigated the impact of maternal FA during
gestation on epigenetic alterations throughout the genome
in a sex-specific manner. Comparison between male and
female pups’ cerebral hemispheres from mothers fed an
LMFA or HMFA revealed significant sexual dimorphism
for global DNA methylation. Approximately 21% of the
CpG sites were differentially methylated between males
and females from both LMFA (n = 55,640) and HMFA
(n = 45,634). The distributions of CpG-island and non-
CpG island associated methylations between male and
female are shown in Additional file 12: Figure S15 and
Additional file 13: Figure S16a,b. The majority of the
DMRs in CpG or non-CpG island between males and fe-
males from LMFA and HMFA were in intergenic or in in-
trons, whereas 9% to 20% in exons and 10% to 21% were
in promoter regions. Further analysis of the data revealed
striking sexual dimorphism in methylation patterns of
numerous genes as a result of both LMFA and HMFA
(Additional file 14: Table S7, Additional file 15: Table
S8, Additional file 16: Table S9, and Additional file 17:
Table S10). The correlation of the distribution of methy-
lation ratios between male and female pups for the cor-
responding sites in LMFA and HMFA is shown in
Additional file 18: Figure S17a,b,c and Additional file 19:
Figure S18a,b,c, and the hexbin plot (Additional file 20:
Figure S19a,b,c) shows the distribution of the overlapped
sites between genders of LMFA and HMFA from total sig-
nificant (P <0.05) differential methylation sites. To evaluate
whether the expressions of the tested genes in this study
were biased by gender, we analyzed the expression of sev-
eral genes between male and female pups from LMFA and
HMFA, which exhibited changes in methylation profile.
First we compared the expression of genes Trap1, Runx1,Scn8a, and Cd47 (hypermethylated) and Auts2 and Rnf111
(hypomethylated) in female pups from LMFA in com-
parison with LMFA from male pups (Additional file 21:
Figure S20a). The results show that the expressions of
Trap1 and Cd47 were significantly downregulated and
the expression of Runx1 was upregulated, whereas the
expressions of Scn8a, Auts2, and Rnf111 remained un-
changed. Similarly, we compared the expression of genes
Dio3, Trim7, Shank3, Slc25a13, Auts2, Disc1, and Dnm3
(hypermethylated) and Bag5, Ghr, Ror2, and Runx1 (hypo-
methylated) in female pups from HMFA in comparison
with HMFA from male pups (Additional file 21: Figure
S20b). The results show that the expressions of Dio3,
Trim7, Shank3, Slc25a13, Auts2, Disc1, Ror2, and Runx1
were upregulated, whereas the expressions of Bag5 and
Ghr were downregulated and the expression of Dnm3
remained unchanged. These results show that expressions
of several genes are biased between male and female pups
both in the basal level (LMFA) and as a result of HMFA.
Moreover, to control and maintain the sexual-dimor
phism hypothesis, we further analyzed the expression of
several tested genes, which exhibited sexual dimorphism
in methylation profile. For example, genes which exhib-
ited changes in methylation level in male pups as a re-
sults of HMFA are tested in female pups (no changes in
methylation profile); similarly, genes which exhibited
changes in methylation level in female pups as a result
of HMFA are tested in male pups (no change in methy-
lation profile). The expression analysis of genes Dio3,
Polg2, Rnf111, Ube2s, Thsz3, Trim7, Gab1, Lats2, and
Slc25a13 (hypermethylated, in female pups) and Mrps12,
Mtap4, and Ceacam2 (hypomethylated in female pups)
were tested in male pups from HMFA in comparison
with male pups from LMFA (Additional file 22: Figure
S21a). The expression of Rnf111 was upregulated and
the expression of Mrps12 (Figure 2c) was downregu-
lated, whereas other tested genes did not exhibit any sig-
nificant changes in male pups. It is interesting to note
that the expressions of Dio3 and Slc25a13 were signifi-
cantly downregulated and the expressions of Thsz3 and
Mtap4 were significantly upregulated in female pups from
HMFA in comparison with LMFA (Figure 2b, d). Similarly,
we tested the expression of several genes in female pups
from HMFA which exhibited no changes in methylation
compared with female pups from LMFA. For example, the
Table 3 List of top 20 hypermethylated CpG sites in the gene body of genes from high maternal folic acid diet








Chr3 138455425 138455426 Tspan5 15 20 0.90 0.00
Chr4 119140980 119140981 Rimkla 21 15 0.79 0.00
Chr4 119140989 119140990 Rimkla 37 16 0.77 0.00
Chr4 119141016 119141017 Rimkla 21 15 0.79 0.00
Chr4 119610724 119610725 Hivep3 11 9 0.89 0.00
Chr8 87012542 87012543 Cacna1a 8 12 0.88 0.00
Chr8 94181294 94181295 Fto 28 22 0.79 0.00
Chr9 15678801 15678802 Mtnr1b 7 10 1.00 0.00
Chr9 106735686 106735687 Vprbp 12 12 1.00 0.00
Chr9 106735687 106735688 Vprbp 20 10 0.90 0.00
Chr9 110562402 110562403 Ccdc12 14 22 0.86 0.00
Chr10 115535492 115535493 Ptprr 14 9 0.86 0.00
Chr13 84421455 84421456 Tmem161b 8 12 0.88 0.00
Chr13 93030034 93030035 Msh3 363 63 0.83 0.00
Chr14 75232739 75232740 Lrch1 18 10 0.89 0.00
Chr15 89378341 89378342 Shank3 17 9 0.83 0.00
Chr18 37951652 37951653 Pcdha4-g 14 10 1.00 0.00
Chr18 60852504 60852505 Ndst1 12 6 1.00 0.00
Chr18 65119073 65119074 Nedd4l 18 17 0.89 0.00
Chr19 31290367 31290368 Prkg1 17 16 0.76 0.00
Female
Chr2 25434932 25434933 Gm996 9 13 0.85 0.00
Chr3 30935498 30935499 Prkci 10 8 1.00 0.00
Chr3 103739555 103739556 Rsbn1 9 15 0.89 0.00
Chr4 126102080 126102081 Eif2c3 19 17 0.74 0.00
Chr4 140978449 140978450 Hspb7 6 19 0.83 0.00
Chr4 150546918 150546919 Camta1 22 6 0.83 0.00
Chr5 65200088 65200089 Klf3 47 36 0.72 0.00
Chr5 103970283 103970284 Ptpn13 23 12 0.74 0.00
Chr5 131698838 131698839 Wbscr17 21 16 0.73 0.00
Chr7 53799845 53799846 Sergef 14 21 0.71 0.00
Chr8 35200739 35200740 Leprotl1 25 10 0.76 0.00
Chr9 8001572 8001573 Yap1 11 15 0.73 0.00
Chr9 42341123 42341124 Grik4 39 30 0.73 0.00
Chr10 88898375 88898376 Gas2l3 14 11 0.82 0.00
Chr11 3211676 3211677 Gm11944 10 35 0.74 0.00
Chr11 115670841 115670842 Caskin2 8 14 0.86 0.00
Chr14 58310412 58310413 Lats2 6 24 1.00 0.00
Chr16 34322324 34322325 Kalrn 12 14 0.71 0.00
Chr17 86912790 86912791 Prkce 8 18 0.89 0.00
Chr19 25161873 25161874 Dock8 16 12 0.75 0.00
HMFA, high maternal folic acid; LMFA, low maternal folic acid.
Barua et al. Epigenetics & Chromatin 2014, 7:3 Page 7 of 15
http://www.epigeneticsandchromatin.com/content/7/1/3
Table 4 List of top 20 hypomethylated CpG sites in the genebody of genes from high maternal folic acid diet








Chr1 182625573 182625574 Mixl1 28 10 −0.76 0.00
Chr2 25376181 25376182 Traf2 24 14 −0.77 0.00
Chr3 37380649 37380650 Spata5 14 18 −0.78 0.00
Chr5 145038432 145038433 Baiap2l1 58 20 −0.87 0.00
Chr5 145038431 145038432 Baiap2l1 28 20 −0.73 0.00
Chr6 63336567 63336568 Grid2 12 11 −0.83 0.00
Chr8 119917212 119917213 Cmip 12 10 −0.80 0.00
Chr9 49203682 49203683 Drd2 14 7 −0.93 0.00
Chr10 86298137 86298138 Nt5dc3 20 6 −0.83 0.00
Chr11 89264853 89264854 4932411E22Rik 12 8 −1.00 0.00
Chr11 88387073 88387074 Msi2 11 10 −0.90 0.00
Chr12 73229241 73229242 Ccdc175 19 6 −0.83 0.00
Chr13 117804995 117804996 Parp8 12 6 −1.00 0.00
Chr16 49910445 49910446 Cd47 8 10 −1.00 0.00
Chr16 96296259 96296260 Brwd1 24 8 −0.83 0.00
Chr17 80761785 80761786 Arhgef33 20 13 −0.77 0.00
Chr17 64485735 64485736 Fert2 9 14 −0.82 0.00
Chr18 36751828 36751829 Ankhd1 20 10 −0.90 0.00
Chr19 5690281 5690282 Map3k11 20 13 −0.80 0.00
ChrX 98171409 98171410 Tex11 10 6 −1.00 0.00
Female
Chr1a 106890569 106890570 Cdh20 15 14 −0.73 0.00
Chr3 53010469 53010470 Lhfp 12 10 −0.92 0.00
Chr4 137849617 137849618 Kif17 9 14 −0.86 0.00
Chr4 142704605 142704606 Prdm2 15 11 −0.73 0.00
Chr4 21913536 21913537 6230409E13Rik 23 10 −0.71 0.00
Chr4 46546442 46546443 Trim14 16 11 −0.75 0.00
Chr4 117003265 117003266 Rnf220 16 6 −0.83 0.00
Chr5 148775977 148775978 Mtus2 20 14 −0.76 0.00
Chr5 37274842 37274843 Ppp2r2c 14 17 −0.75 0.00
Chr8 121359642 121359643 Cdh13 17 10 −0.74 0.00
Chr9 21909321 21909322 Cnn1 10 6 −1.00 0.00
Chr9 44605440 44605441 Tmem25 16 10 −0.75 0.00
Chr11 96309521 96309522 Gm11529 25 10 −0.88 0.00
Chr11 118204319 118204320 Timp2 20 7 −0.81 0.00
Chr11 98634354 98634355 Nr1d1 7 15 −0.87 0.00
Chr15 99627500 99627501 Lima1 25 22 −0.74 0.00
Chr15 59208541 59208542 Nsmce2 9 6 −1.00 0.00
Chr16 49910445 49910446 Cd47 10 12 −0.83 0.00
Chr17 26016873 26016874 Wfikkn1 36 20 −0.73 0.00
Chr17 28437426 28437427 Ppard 8 22 −0.83 0.00
aMethylation exclusively in the CpG island. HMFA, high maternal folic acid; LMFA, low maternal folic acid.
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Figure 2 Relative expression of the genes that exhibited hypermethylation (a, b) and hypomethylation (c, d). The results were normalized to
Hprt transcript expression and were expressed as relative values in comparison with corresponding transcripts from low maternal folic acid (LMFA).
Results represent mean ± standard deviation (SD); asterisks denote statistically significant change (*P <0.05, **P <0.01, ***P <0.001).
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C07Rik, Mthfd1l, Nfix, Otoa, and Slc22a3 (hypermethy-
lated in male pups) and Pcnxl3, Hmgb2l1, and Ror2 (hypo-
methyalted, in male pups) were tested. The results showed
(Additional file 22: Figure S21b) that the expression of
Ada, Bag5, and Slc22a3 were unchanged in female pups
from HMFA in comparison with LMFA. In contrast, the
expressions of Ghr and Nfix were upregulated in female
pups from HMFA. It is interesting to note that the ex-
pression of Otoa is downregulated whereas the expres-
sions of Trap1, 4732418C07Rik, Mthfd1l, Pcnxl3, Hmgb2l1,
and Ror2 remained unchanged in both male and female
pups as results of HMFA. These results show that the ex-
pressions of several tested genes are sexually biased as a re-
sult of HMFA. Additionally, we have evaluated that the
methylation patterns were affected in cis-alteration in CpG
and CHG contexts in both males and females (Additional
file 23: Table S11).
Discussion
In a fertilized egg, global DNA demethylation followed
by remethylation occurs to reprogram the maternal and
paternal genomes for efficient regulation of gene expres-
sion. Certain genes are turned on and off at particular
time intervals, and any disruption of such highly orches-
trated methylation regulation may impact gene expression.The fetal epigenome is most vulnerable during this period
of development to epigenetic modifiers in the maternal
microenvironment. Because lifestyle and the level of nutri-
tion available during gestation play an important role in
the offsprings’ gene regulation, maternal FA consumed
could dictate the establishment of epigenetic patterns of
the offspring. In this study, we found that HMFA during
gestation resulted in substantial changes in the methyla-
tion profile of the offspring’s cerebral hemispheres. Over
the years, numerous studies have implicated several candi-
date autism susceptibility genes with a logical focus on the
affected child. However, a consistent picture of specific
susceptibility loci has thus far met with limited success
[16-18]. In humans, FA during gestation has been shown
to prevent autism or NTDs [19-21]. Intriguingly, our re-
sults showed hypermethylation but no hypomethylation in
the promoter region of candidate autistic and imprinted
genes in the offspring from the HMFA group. In this
study, we found that HMFA resulted in hypermethylation
(P <0.01) at the CpG sites of the promoter region of Ada
in male offspring. It is noteworthy that previous evidence
had suggested decreased Ada activity in autistic subjects
[22-24] and in a severe combined immune deficiency
syndrome [25,26]. Thus, such changes in methylation pat-
terns in promoter CpG sites due to HMFA may have long-
term influences on neuronal organization and behavioral
Figure 3 Distribution of differentially methylated sites in non CpG (CHG/CHH) sites. (a) Male low maternal folic acid (LMFA) versus high
maternal folic acid (HMFA). (b) Female LMFA versus HMFA.
Barua et al. Epigenetics & Chromatin 2014, 7:3 Page 10 of 15
http://www.epigeneticsandchromatin.com/content/7/1/3phenotypes. In addition, epigenetic modifications of the
imprinted genes such as Dio3 can result in clinically sig-
nificant phenotypes. It will be of interest to examine the
impact of the dose and duration of maternal FA and the
consequences of these epigenetic effects. Similar to
hypermethylation, we observe hypomethylation in pro-
moter regions of CpG sites in both male and female
pups from HMFA in comparison with LMFA. The expres-
sion of Ror2 (hypomethylated in male pups) which plays a
role during neurogenesis of the developing neocortex [27]was significantly downregulated in male pups, but no such
changes were observed in female pups. Moreover, the ex-
pression of Mtap4 (hypomethylated in female pups) that
has been shown to play a role in the central nervous sys-
tem and regulation of the microtubule-dependent trans-
port [28] was upregulated significantly in female pups from
HMFA in comparison with LMFA, but the expression in
male pups did not exhibit such significant changes. Intri-
guingly, the expression of Mrsps12 that exhibited hypome-
thylation in female pups from HMFA remained unchanged
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of Mrps12 in male pups was significantly downregulated
in HMFA in comparison with LMFA, although no such
changes in methylation pattern were observed. Of note,
Mrps12 is a major component of the ribosomal accuracy
center and has been shown to play a role in sensori-
neural deafness [29].
Recently, the methylation of non-CpG regions and its role
in transcriptional repression have received greater attention
[30,31], and single-base resolution maps of the human gen-
ome have revealed a substantial presence of methylated
cytosine residues in non-CpG contexts [32]. In this study,
we found substantial differential methylation in non-CpG
regions in gene promoters from newborns of HMFA and
confirmed the variations in the expression of several genes.
Notably, studies using the brain tissue from an Alzheimer
disease model [33], fetal brain [34,35], adult tissues [36,37],
and early embryo [38] have shown that methylation in both
CpG islands and non-CpG regions correlates with the ex-
pression of several genes. Thus, variation of methylation in
the non-CpG regions as a result of HMFA may modulate
epigenetic-mediated transcriptional repression, although a
direct causal connection cannot be established with our
data. Further analysis of the methylation profile has shown
substantial differential methylation in the gene body of the
offspring DNA. This finding builds on growing evidence
that maternal adversity during gestation induces unbiased
epigenetic changes in offspring genome. Although aberrant
methylation in gene promoter regions is known to be linked
with altered gene expression, the effect of hypermethylation
in the gene body is unclear and inconclusive [39]. Signifi-
cant evidence indicates that gene body methylation is a gen-
eral feature of highly expressed genes in human cell lines
[40-42]. In contrast, a recent study in a mouse model has
revealed that differential gene body methylation generally
resulted in downregulation of gene expression [43]. We
found both up- and downregulation in the expression of
transcripts that exhibited hypermethylation in the gene
body of the offspring from HMFA. Our study suggests that
the relationship between gene body methylation and tran-
scriptional level may be more complicated than previously
thought and, perhaps, underappreciated. Intriguingly the
mRNA expression of Shank3 was significantly downregu-
lated in both male and female pups; in contrast, the expres-
sion of Auts2 is downregulated in male pups but not in
female pups. The genes Auts2 and Shank3 are associated
with autism spectrum disorders and other neurological dis-
eases [44,45], and in this study both of the genes exhibited
an alteration in methylation pattern in the gene body.
Our findings showed several distinct DMRs to be acting
in a sexually dimorphic manner, similar to a recent study
on imprinted genes in the placenta [46]. The relevance of
epigenetic mechanisms in developing several complex dis-
eases is sex-biased, and numerous studies have shown thatduring the developing windows of life the environmental
factors, including nutrition during prenatal and postnatal
life, influence epigenetic modulation in a sex-related man-
ner [47-50]. Several studies in humans have further shown
that various late-onset diseases are sex-biased and are
highly related to maternal diet and body condition during
pregnancy [51-53]. In this study, in the mouse model, we
found that the expressions of several genes as a result of
HMFA are highly biased in expression depending upon
the gender. Furthermore, analysis of the methylation pro-
file and gene expression between LMFA of male and fe-
male pups and between HMFA of male and female pups
reveals striking sexual dimorphism. One possibility of such
sexual dimorphism is the alterations in the uterine envir-
onment because of changes in FA level, and the methyla-
tion of imprinted genes may fine-tune selective events
specific to one sex during developmental programming.
Thus, the results of our study further highlight the rele-
vance of studying both sexes in experimental models of
maternal diet and may provide critical insight regarding
the influence of FA in programming sex-biased methyla-
tion pattern.
It is paradoxical that the methylation profile of our find-
ings shows a substantial hypomethylation to be present in
the offspring DNA, even after supplementing HMFA. This
finding indicates that the amount of gestational extra-
cellular FA or cofactor required for the synthesis of S-
adenosylmethionine probably can induce the site- and
gene-specific nature of the methylation level in the off-
spring DNA, and probably the DNA methylation status
is also dependent upon methylenetetrahydrofolate re-
ductase (MTHFR) activity and not only on the folate
status alone [54,55]. Moreover, because DNA methylation
is a distinguishing feature that varies between cell types,
specifically various neuronal populations, the variation in
methylation (hypo/hyper) profile of our sample may be
due to the cellular heterogeneity of the cerebral hemi-
sphere [56-58].
Methods
Mice strain and feeding
Mice in this study were handled according to the proto-
col reviewed and approved by the Institute for Basic
Research Institutional Animal Care and Use Committee.
Adult, 8- to 10-week-old C57BL/6 J mice were used in all
the experiments. Throughout the experimental procedure,
controlled temperature and a fixed lighting schedule were
maintained in the room. Given that most current com-
mercial mice chow already contains quite high amounts of
FA (2–3 mg/kg diet) and thus is unsuitable for the current
studies, we developed a custom diet for this study. One
week prior to mating, female mice were fed with a custom
AIN-93G amino acid-based diet (Research Diet, Inc.), hav-
ing FA at 0.4 mg/kg (n = 8–12), while the test group
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ued throughout the entire period of gestation.
Tissue collection and DNA extraction
At postnatal day 1, six pups (n = 6, segregated by gender),
all from different dams, in each diet group were sacrificed.
Cerebral hemisphere tissues were pooled (n = 3/gender)
for the 0.4 mg group: three male pups (each from an inde-
pendent dam) and three female pups (each from an inde-
pendent dam), for a total of six pups (n = 6). Tissues from
six pups (n = 6, segregated by gender) from the 4 mg group
were similarly processed. DNA was extracted from pooled
cerebral hemispheres (n = 3/gender per group) with the
Epicentre MasterPure DNA purification kit (Epicentre
Biotechnologies, Madison, WI, USA) in accordance with
the protocol of the manufacturer. After re-suspension in
TE buffer, the DNA concentration was measured by using
NanoDrop ND-1000 (Thermo Scientific, Wilmington,
DE, USA).
Library construction
To perform a genome-wide DNA methylation analysis,
libraries were prepared from 200 to 500 ng of genomic
DNA digested sequentially with 60 units of TaqI and 30
units of MspI (New England Biolabs, Ipswich, MA,
USA). The resulting size-selected TaqI-MspI fragments
(40–120 bp and 120–350 bp) were filled in, and 3′-
terminal-A extended, extracted with DNA Clean &
Concentrator™ kit (Zymo Research, Irvine, CA, USA).
Ligation of selected fragments to pre-annealed adapters
containing 5′-methyl-cytosine instead of cytosine was per-
formed by using the Illumina DNA preparation kit in ac-
cordance with the protocol of the manufacturer (Illumina
Inc., San Diego, CA, USA). Purified, adaptor-ligated frag-
ments were then bisulphite-treated by using the EZ DNA
Methylation-Direct™ Kit (Zymo Research). Preparative-
scale PCR was performed with the resulting fragments
followed by purification of PCR products with DNA Clean
& Concentrator™ (Zymo Research). Final size selection of
the purified PCR products was performed by using 4%
NuSieve 3:1 agarose gel. SYBR-green-stained gel slices of
adapter-ligated fragments (130–210 bp or 210–460 bp in
size) were excised, and library material was recovered by
using the Zymoclean™ Gel DNA Recovery Kit (Zymo
Research). Sequencing was performed on an Illumina
HiSeq genome analyzer.
Sequence alignments and data analysis
Using standard base-calling software, sequence reads
from bisulfite-treated EpiQuest libraries were identified.
Further analysis was performed by using a Zymo Re-
search proprietary analysis pipeline. First, residual cyto-
sines (Cs) in each read were converted to thymines (Ts),
with each conversion noted for subsequent analysis. Fromthe 50-bp ends of each computationally predicted MspI-
TaqI fragment (40- to 350-bp size range), a reference se-
quence database was constructed. All Cs in each fragment
end were then converted to Ts; only the C-poor strands
are sequenced in the RRBS (reduced representation bisul-
fite sequencing) process. Then, using Bowtie software
(http://bowtie-bio.sourceforge.net/index.shtml), the con-
verted reads were aligned to the converted reference. The
number of mismatches in the induced alignment was then
counted between the unconverted read and reference, ig-
noring cases in which a T in the unconverted read was
matched to a C in the unconverted reference. For a given
read, the best alignment was kept if the second-best align-
ment had two more mismatches; otherwise, the read was
discarded as non-unique. The methylation level of each
sampled C was estimated as the number of reads report-
ing a C, divided by the total number of reads reporting a
C or T. For each CpG site, Fisher’s exact test or t test was
performed, which covered at least five reads. Also, pro-
moter, gene body, and CpG island annotations were added
for each CpG. The software pipeline is implemented in
Python. All the procedures above were carried out in the
Zymo Epigentic Core Services (Zymo Research).
RNA preparation and quantitative real time reverse
transcription-polymerase chain reaction analysis
At postnatal day 1, six pups (n = 6, segregated by gender)
from different dams in each diet group were sacrificed.
Cerebral hemisphere tissues were pooled (n = 3/gender)
for the 0.4 mg group: three male pups (each from an in-
dependent dam) and three female pups (each from an
independent dam), for a total of six pups (n = 6). Tissues
from six pups (n = 6) from the 4 mg group were similarly
processed. Considering the degree of inter-variability,
RNA extractions were repeated from a different batch
(pooled samples, n = 3 for each group/gender, with each
mouse from a different dam). Total RNA was extracted
by lysing the cells with Trizol reagent (Invitrogen Life
Technologies, Inc., Carlsbad, CA, USA). Further purifi-
cation of RNA was carried out using RNeasy kit (Qiagen,
Valencia, CA, USA) in accordance with the instructions
of the manufacturer. On-column DNase digestion for
each sample was performed to remove any DNA contam-
ination. The quality of RNA was assessed by measuring the
absorbance ratio at 260/280 nm by using NanoDrop ND-
1000 (Thermo Scientific). The integrity of RNA was further
assessed by formaldehyde-gel electrophoresis. Quantitative
real time reverse transcription-polymerase chain reaction
amplifications were performed with either One-Step iScript
kit (Bio-Rad, Hercules, CA, USA) or Two-step kit in which
the first-strand cDNA from each sample was synthesized
from 1 μg total RNA by using the First-Strand cDNA Syn-
thesis kit (Affymetrix, Santa Clara, CA, USA) in accord-
ance with the protocol of the manufacturer. qRT-PCR was
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(Eppendorf AG, Hamburg, Germany) in combination with
the RT2 SYBRGreen PCR Master Mix (Qiagen). Each reac-
tion was run in duplicate and repeated at least two times
each from different batches of RNA (pooled n = 3 per
batch/gender). Hprt1 was used as endogenous control for
amplification. Relative gene expression was calculated by
using the Pfaffl method [59]. Primers used for qRT-PCR
are listed in Additional file 24: Table S12. Statistical analysis
was done by using Prism Software (GraphPad, San Diego,
CA, USA). Values are presented as means ± standard
deviation, and numerical results are presented consider-
ing P <0.05 as significant.
Conclusions
In summary, we have identified substantial DMRs in the
cerebral hemispheres of the offspring, revealing that the
HMFA diet causes epigenetic modifications. A key finding
of this study is the presence of DMRs in non-CpG regions,
along with CpG sites at single-base resolution, as a result of
HMFA. Because numerous studies have shown that abnor-
malities in the frontal lobes impact brain development and
autism [60,61], our study’s findings could provide a com-
pletely novel insight into the etiology of complex develop-
mental disorders and foster the development of corrective
strategies. However, we do not rule out the limitation of
our study that the methylation and gene expression do not
necessarily indicate change in function, and thus further
studies are required in a larger number of samples to verify
the functional outcome and phenotypes.
Additional files
Additional file 1: Table S1. Descriptive statistics of the mapping of
methylation profile of the cerebral hemispheres of offspring from low
maternal folic acid (LMFA) and high maternal folic acid (HMFA) diets.
Additional file 2: Table S2. Genes in male offspring from high maternal
folic acid (HMFA) diet, which were enriched with methylation in the gene
body and other chromosomal regions in CpG/CHG/CHH contexts.
Additional file 3: Table S3. Genes in female offspring from high
maternal folic acid (HMFA), which were enriched with methylation in the
gene body and other chromosomal region in CpG/CHG/CHH contexts.
Additional file 4: Table S5. Genes that were hypomethylated in the
CpG/CHG/CHH contexts of the male offspring from high maternal folic
acid (HMFA) diet.
Additional file 5: Table S6. Genes that were hypomethylated in the
CpG/CHG/CHH region of the female offspring from high maternal folic
acid (HMFA) diet.
Additional file 6: Figures S1-S6. Scatter plot representing the distribution
of the methylation ratio for corresponding sites of low maternal folic acid
(LMFA) versus high maternal folic acid (HMFA). Pearson’s correlation coefficient
is denoted in the center of each scatter plot.
Additional file 7: Figures S7-S9. Hexbin plot representing the
overlapped sites in CpG (n = 4,378), CHG (n = 71), and CHH (n = 149)
regions between male and female pups from high maternal folic acid
(HMFA) in comparison with low maternal folic acid (LMFA) from total
significant (P <0.05) differential methylation sites. Each dot in hexbin plot
is one of the overlapped sites. The colors blue, green, yellow and redrepresent the dot density from lower to higher order in accordance with
the prevalence of the overlapping sites.
Additional file 8: Figures S10, S11. Box plot illustrating the
methylation levels across non-CpG islands of the cerebral hemispheres
from male pups (S10) having low maternal folic acid (LMFA) (n = 36,319
and median = 0.65) and high maternal folic acid (HMFA) (n = 36,319 and
median = 0.73) and from female pups (S11) having LMFA (n = 48,438
and median = 0.66) and HMFA (n = 48,438 and median = 0.69) as assessed
by reduced representation bisulfite sequencing (RRBS). Boxes are 25th and
75th quartiles; horizontal yellow bar in the middle represents the median
DNA methylation value. Whisker indicates the 5th and 95th percentiles.
Additional file 9: Table S4. Genes in male and female offspring from
high maternal folic acid (HMFA), which were enriched with methylation
in the gene promoters in CHG/CHH.
Additional file 10: Figure S12. A representative figure of the data
uploaded in the University of California at Santa Cruz (UCSC) Genome
Browser. Comparison of DNA methylation patterns in the offspring’s
cerebral hemisphere from low maternal folic acid (LMFA) and high
maternal folic acid (HMFA). Example of the Slc5a1 gene in chromosome 5
that was differentially methylated in the CHG contexts of promoter
region of male offspring. Yellow color bars indicate gain of methylation.
Additional file 11: Figures S13, S14. Box plot illustrating the
methylation levels across exons of the cerebral hemispheres from male pups
(S13) having low maternal folic acid (LMFA) (n = 8,136 and median = 0.42)
and high maternal folic acid (HMFA) (n = 8,136 and median = 0.5) and from
female pups (S14) having LMFA (n = 10,335 and median = 0.44) and HMFA
(n = 10,335 and median = 0.5) as assessed by reduced representation
bisulfite sequencing (RRBS). Boxes are 25th and 75th quartiles; horizontal
yellow bar in the middle represents the median DNA methylation value.
Whisker indicates the 5th and 95th percentiles.
Additional file 12: Figure S15. Distribution of differentially methylated
sites in CpG island sequences between males and females from (a) low
maternal folic acid (LMFA) and (b) high maternal folic acid (HMFA).
Additional file 13: Figure S16. Distribution of differentially methylated
sites in non CpG island sequences between males and females from (a)
low maternal folic acid (LMFA) and (b) high maternal folic acid (HMFA).
Additional file 14: Table S7. Genes in female offspring from low
maternal folic acid (LMFA) diet, which were enriched with methylation,
compared with male offspring in the CpG/ CHG/CHH contexts.
Additional file 15: Table S8. Genes in female offspring from low
maternal folic acid (LMFA) diet, which were hypomethylated, compared
with male offspring in the CpG/CHG/CHH contexts.
Additional file 16: Table S9. Genes in female offspring from high
maternal folic acid (HMFA) diet, which were enriched with methylation,
compared with male offspring in the CpG/CHG/CHH contexts.
Additional file 17: Table S10. Genes in female offspring from high
maternal folic acid (HMFA) diet, which were hypomethylated, compared
with male offspring in the promoter region in CpG/CHG/CHH contexts.
Additional file 18: Figures S17 (a, b, c). Scatter plot representing the
distribution of the methylation ratio for corresponding sites of low
maternal folic acid (LMFA) male versus LMFA female in CpG/CHG/CHH
regions. Pearson’s correlation coefficient is denoted in the center of each
scatter plot.
Additional file 19: Figures S18 (a, b, c). Scatter plot representing the
distribution of the methylation ratio for corresponding sites of high
maternal folic acid (HMFA) male versus HMFA female in CpG/CHG/CHH
regions. Pearson’s correlation coefficient is denoted in the center of each
scatter plot.
Additional file 20: Figures S19 (a, b, c). Hexbin plot representing the
overlapped sites in CpG (n = 6,085), CHG (n = 96), and CHH (n = 154)
regions between male and female pups from LMFA compared with high
maternal folic acid (HMFA) pups from total significant (P <0.05)
differential methylation sites. Each dot in hexbin plot is one of the
overlapped sites. The colors blue, green, yellow, and red represent the
dot density from lower to higher order in accordance to the prevalence
of the overlapping sites.
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http://www.epigeneticsandchromatin.com/content/7/1/3Additional file 21: Figure S20a. Quantitative real time reverse
transcription-polymerase chain reaction (qRT-PCR ) showing relative
expression of the transcripts of genes in female pups that exhibited
hypermethylation or hypomethyaltion in the cerebral hemispheres in
comparison with male pups from low maternal folic acid (LMFA). The
results were normalized to Hprt transcript expression and were expressed
as relative values in comparison with corresponding transcripts from male
LMFA. Results represent mean ± standard deviation (SD); asterisks denote
statistically significant change (*P <0.05, **P <0.01, ***P <0.001). Figure S20b.
qRT-PCR showing relative expression of the transcripts of genes in female
pups that exhibited hypermethylation or hypomethyaltion in the cerebral
hemispheres in comparison with male pups from high maternal folic acid
(HMFA). The results were normalized to Hprt transcript expression and were
expressed as relative values in comparison with corresponding transcripts
from male HMFA. Results represent mean ± SD; asterisks denote statistically
significant change (*P <0.05, **P <0.01, ***P <0.001).
Additional file 22: Figure S21a. Quantitative real time reverse
transcription-polymerase chain reaction (qRT-PCR) showing relative
expression of the transcripts of genes in male pups from high maternal folic
acid (HMFA) that exhibited no alterations in the methylation profile in
promoter and gene body in the cerebral hemispheres compared with low
maternal folic acid (LMFA). The results were normalized to Hprt transcript
expression and were expressed as relative values in comparison with
corresponding transcripts from LMFA. Results represent mean ± standard
deviation (SD); asterisks denote statistically significant change (*P <0.05,
**P <0.01, ***P <0.001). Figure S21b. qRT-PCR showing relative expression
of the transcripts of genes in female pups from HMFA that exhibited no
alterations in the methylation profile in promoter and gene body in the
cerebral hemispheres compared with LMFA. The results were normalized to
Hprt transcript expression and were expressed as relative values in
comparison with corresponding transcripts from LMFA. Results
represent mean ± SD; asterisks denote statistically significant change
(*P <0.05, **P <0.01, ***P <0.001).
Additional file 23: Table S11. List of top 100 sites, sorted by P value,
which exhibited cis-alterations in male and female offspring in the CpG/
CHG contexts.
Additional file 24: Table S12. List of primers used for quantitative real
time reverse transcription-polymerase chain reaction (qRT-PCR) in this study.
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